Intravesical Bacillus Calmette-Guerin (BCG) therapy after transurethral resection of bladder tumor is considered the most effective treatment for prophylaxis against the recurrence of high risk nonmuscle invasive bladder cancer, and generally well tolerated and infectious complication are rare. We reported a case of granulomatous prostatitis is a patient who had undergone intravesical BCG therapy due to nonmuscle invasive bladder cancer. This patient was diagnosed by prostate biopsy because of prostate-specific antigen elevation without any other voiding symptoms and abnormal abscess pocket in transrectal ultrasonography. (Korean J Urol Oncol 2017;15:85-87)
INTRODUCTION
Bacillus Calmette-Guerin (BCG) intravesical instillation therapy, which is commonly performed as adjuvant chemotherapy following transurethral resection of bladder tumor (TURB), is the golden standard treatment for patients with high grade nonmuscle invasive bladder cancer ( Ta & T1) . 1 This therapy is generally safe but may rarely be complicated by granulomatous prostatitis. 2 However, the patient in this case report showed no signs of recurrent cancer, and was diagnosed with active prostate tuberculosis in a biopsy performed after observing prostate-specific antigen (PSA) elevation not accompanied by voiding or systemic symptoms. The biopsy was performed 5 years after the patient underwent BCG intravesical therapy. Here, we report the treatment of this patient.
CASE REPORT
A 59-year-old male patient who had no previous history of tuberculosis visited our clinic for abrupt onset gross hematuria served, PSA levels that were coincidentally measured were high. When the patient visited our clinic in 2015, a PSA level of 3.08 ng/mL was found, higher than that measured in 2008 of 0.76 ng/m, and was later elevated to 4.07 ng/mL. However, the patient had no voiding symptoms or subjective symptoms such as perineal discomfort, and no abnormal findings were made in transrectal prostate ultrasonography with regard to prostate volume, which was 27 g, and abscess pocket (Fig. 1) .
Because the patient's PSA level continued to elevate, the pa- therapy. 4 While it has been reported that asymptomatic granulomatous prostatitis does not require treatment even if the patient is acid-fast bacilli positive, 5 patients with continuous asymptomatic PSA elevation must be assessed for prostate cancer through a prostate biopsy. To our knowledge, there has not been a case in which a patient began treatment for prostate cancer that was diagnosed in a biopsy performed after observation of PSA elevation more than 6 years after undergoing BCG intravesical instillation therapy. Therefore, when a patient shows 
